Shivam Tyagi

The author works as a Correspondent with BW Businessworld

Latest Articles By Shivam Tyagi

India Must Focus On Biopharmaceuticals To Feed The Growth Engine: Kiran Mazumdar Shaw

Shivam Tyagi

In an exclusive conversation with BW Healthcare World, Kiran Mazumdar Shaw, Executive Chairperson, Biocon & Biocon Biologics delineates on how Indian pharma can move up the value chain, while also speaking on Biocon's R&D investments and future plans

E-pharmacies Might Go Down, Industry Expert Says Shutting Shops Not A Solution

Shivam Tyagi

Economy

Online pharmacies in India like Tata 1mg, Netmeds and Pharmeasy among others are in troubled waters again as media reports say that the pharmacies might face a complete ban over the online sale of drugs for alleged violation of norms

Rethinking Procurement Strategy of Healthcare Institutions

Shivam Tyagi

Economy

Indian medical technology industry is moving in the right direction with exciting times ahead although the sector needs improvements in many aspects and still has a long way to go to reduce the 80 to 85 per cent import dependency of the Indian healthcare system when it comes to using medical devices in hospitals and diagnostic labs

Single Drug Regulatory Framework

Shivam Tyagi

Healthcare

Chennai-based drug firm, Global Pharma Healthcare, voluntarily recalled its whole batch of eye drops after the USFDA notification alleged that they had caused a death and 55 instances of eye infections and permanent loss of vision

Biocon Reports Net Loss Of Rs 42 Cr, Sales Up By 36% YoY In Q3FY23

Shivam Tyagi

Economy

Biocon's revenue for the third quarter stood at Rs 3,020 crores against Rs 2,223 crores in the same quarter last year. Whereas the company posted a net loss of Rs 42 crores in quarter three of the financial year 2023(Q3FY23

BW Exclusive | Price Erosion In US Hurting Generic Pharma Industry Says RK Baheti, CFO, Alembic Pharma

Shivam Tyagi

Economy

In an exclusive interaction with BW Healthcare World, RK Baheti, CFO, Alembic Pharmaceuticals speaks on the headwinds for generics, the progress of PLI schemes in pharma, updates on the USFDA inspections, takeaways from the budget and the company's outlook in the upcoming financial year

Our Hospital Setups With All Facilities Cost Us Rs 10-15 Lakhs Per Bed Versus Rs 1.5 Cr Per Bed: Dr Shuchin Bajaj

Shivam Tyagi

Economy

Dr Shuchin Bajaj, Founder Director, Ujala Cygnus Hospitals speaks with BW Healthcare World on the evolving scenario of tier 2 and tier 3 cities, maintaining profitability, operating on low costs, leveraging technology and overcoming challenges of delivering healthcare in the towns

Alembic Pharma's PAT Slumps By 29% YoY In Q3FY23

Shivam Tyagi

Economy

Alembic Pharma recorded a Profit After Tax (PAT) of Rs 122 crores in quarter three of the financial year 2023 (Q3FY23) against Rs 171 crores recorded in the corresponding quarter of the previous year, a 29 per cent slump year on year

Healthcare Budget Advances By 3.4 %, Major Schemes See Downfall In Allocation

Shivam Tyagi

Economy

The overall budget outlay given to the Ministry of Health and Family Welfare has increased by 3.42 per cent against Rs 86,200 crores given in the FY2021-22. While the health research corpus dipped by 6.8 per cent from Rs 3,200 crores in the FY22-23, a contraction of Rs 220 crores

Q3 Results: Glenmark's PAT Dips By 1.2% QoQ, Revenue At Rs 540 Cr

Shivam Tyagi

Economy

Glenmark Pharmaceuticals recorded a net profit of Rs 105 crores in quarter three of the financial year 2023(Q3FY23) against Rs 103.7 crores recorded in the corresponding quarter in the previous year, a 1.2 per cent jump year on year while the PAT dropped by 1.2 per cent quarter on quarter